Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2005 4
2006 4
2007 8
2008 8
2009 4
2011 3
2012 7
2013 4
2014 1
2015 5
2016 5
2017 1
2018 3
2019 1
2020 8
2021 10
2022 5
2023 2
2024 5
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Unsever
Page 1
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
Lu YS, Mahidin EIBM, Azim H, Eralp Y, Yap YS, Im SA, Rihani J, Gokmen E, El Bastawisy A, Karadurmus N, Lim YN, Lim CS, Duc LT, Chung WP, Babu KG, Penkov K, Bowles J, Alfaro TD, Wu J, Gao M, Slimane K, El Saghir NS. Lu YS, et al. J Clin Oncol. 2024 Aug 10;42(23):2812-2821. doi: 10.1200/JCO.24.00144. Epub 2024 May 21. J Clin Oncol. 2024. PMID: 38771995 Free PMC article. Clinical Trial.
METHODS: In this open-label, multicenter, randomized phase II trial, pre/perimenopausal women with clinically aggressive HR+/HER2- ABC were randomly assigned 1:1 to first-line ribociclib (600 mg once daily; 3 weeks on, 1 week off) plus letrozole/anastrozole and goserelin or inves …
METHODS: In this open-label, multicenter, randomized phase II trial, pre/perimenopausal women with clinically aggressive HR+/HER2- ABC were …
Thalassemia.
Aydinok Y. Aydinok Y. Hematology. 2012 Apr;17 Suppl 1:S28-31. doi: 10.1179/102453312X13336169155295. Hematology. 2012. PMID: 22507773 Free article.
The effect of virtual reality on pain, fear, and anxiety during access of a port with huber needle in pediatric hematology-oncology patients: Randomized controlled trial.
Gerçeker GÖ, Bektaş M, Aydınok Y, Ören H, Ellidokuz H, Olgun N. Gerçeker GÖ, et al. Eur J Oncol Nurs. 2021 Feb;50:101886. doi: 10.1016/j.ejon.2020.101886. Epub 2020 Dec 1. Eur J Oncol Nurs. 2021. PMID: 33321461 Clinical Trial.
Before and after the port needle insertion procedure, anxiety and fear assessed using self- and parent-report using the Children's Anxiety Meter and Child Fear Scale. The primary outcome was the patient-reported pain scores after the procedure and fear and anxiety scores b …
Before and after the port needle insertion procedure, anxiety and fear assessed using self- and parent-report using the Children's An …
Venous ulcers in Behçet syndrome.
Karakoc A, Ozguler Y, Ozdede A, Ferhatoglu ZA, Yildiz KA, Kutlubay Z, Karagoz SH, Adaletli I, Ulgen OA, Esatoglu SN, Hatemi G, Melikoglu M, Seyahi E. Karakoc A, et al. Semin Arthritis Rheum. 2025 Apr;71:152643. doi: 10.1016/j.semarthrit.2025.152643. Epub 2025 Jan 28. Semin Arthritis Rheum. 2025. PMID: 39929007
INTRODUCTION: Post-thrombotic syndrome (PTS) and stasis ulcers are late complications of deep vein thrombosis (DVT) in Behcet's syndrome (BS). We aimed to determine the clinical and histopathological characteristics, treatment modalities, and outcomes in BS patients with s …
INTRODUCTION: Post-thrombotic syndrome (PTS) and stasis ulcers are late complications of deep vein thrombosis (DVT) in Behcet's syndr …
Iron Chelation Therapy as a Modality of Management.
Aydinok Y. Aydinok Y. Hematol Oncol Clin North Am. 2018 Apr;32(2):261-275. doi: 10.1016/j.hoc.2017.12.002. Epub 2018 Jan 17. Hematol Oncol Clin North Am. 2018. PMID: 29458731 Review.
Infliximab for vascular involvement in Behcet's syndrome.
Hatemi G, Tukek NB, Esatoglu SN, Ozguler Y, Taflan SS, Uygunoglu U, Melikoglu M, Ugurlu S, Fresko I, Siva A, Kutlubay Z, Yurdakul S, Yazici H, Hamuryudan V. Hatemi G, et al. Clin Immunol. 2023 Aug;253:109682. doi: 10.1016/j.clim.2023.109682. Epub 2023 Jun 28. Clin Immunol. 2023. PMID: 37385325
OBJECTIVE: Vascular involvement is an important cause of morbidity and mortality in patients with Behcet's syndrome (BS). We aimed to survey the efficacy and safety of infliximab (IFX) in BS patients with vascular involvement followed in a dedicated tertiary center. ...
OBJECTIVE: Vascular involvement is an important cause of morbidity and mortality in patients with Behcet's syndrome (BS). We aimed to …
Updated approach for the management of osteoporosis in Turkey: a consensus report.
Kirazlı Y, Atamaz Çalış F, El Ö, Gökçe Kutsal Y, Peker Ö, Sindel D, Tuzun Ş, Gogas Yavuz D, Durmaz B, Akarirmak Ü, Bodur H, Hamuryudan V, Inceboz U, Öncel S. Kirazlı Y, et al. Arch Osteoporos. 2020 Aug 29;15(1):137. doi: 10.1007/s11657-020-00799-0. Arch Osteoporos. 2020. PMID: 32860546 Free PMC article. Review.
Neuroprotective effects of L-Dopa-modified zinc oxide nanoparticles on the rat model of 6-OHDA-induced Parkinson's disease.
Yeni Y, Genc S, Ertugrul MS, Nadaroglu H, Gezer A, Mendil AS, Hacımuftuoglu A. Yeni Y, et al. Sci Rep. 2024 Aug 17;14(1):19077. doi: 10.1038/s41598-024-69324-4. Sci Rep. 2024. PMID: 39154054 Free PMC article.
Parkinson's disease (PD) is a chronic neurodegenerative case. As the disease progresses, the response time to doses of levodopa (L-Dopa) becomes shorter and the effects of the drug are severely limited by some undesirable side effects such as the 'on-off' phenomenon. In se …
Parkinson's disease (PD) is a chronic neurodegenerative case. As the disease progresses, the response time to doses of levodopa (L-Do …
ORPHEE: A Real-World Study on rIX-FP Prophylaxis Use in Adolescent/Adult Patients With Hemophilia B.
Volot F, Castet S, Fournel A, Frotscher B, Gillet B, Desprez D, Tardy B, Rauch A, Chamouni P, Biron-Andreani C, Valentin JB, Harroche A, Dargaud Y, Petesch BP, d'Oiron R, Berger C, Reynes C, Lauvray T, de Raucourt E, Hassoun A, Lebreton A, Cussac V, Catovic H, Martin C, Guillet B. Volot F, et al. Eur J Haematol. 2025 Mar;114(3):508-516. doi: 10.1111/ejh.14357. Epub 2024 Dec 5. Eur J Haematol. 2025. PMID: 39638755 Free PMC article.
Annualized (spontaneous) bleeding rates [A(s)BRs] were calculated only in patients on prophylaxis with a follow-up 6 months. RESULTS: This interim analysis focused on 77 patients 12 years; 62 (81%) had severe HB. ...
Annualized (spontaneous) bleeding rates [A(s)BRs] were calculated only in patients on prophylaxis with a follow-up 6 months. RESULTS: …
Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya.
Oduor MA, Lotodo TC, Vik TA, Manyega KM, Loehrer P, Omondi AA, Oguda JO, Asirwa FC. Oduor MA, et al. JCO Glob Oncol. 2021 Mar;7:400-407. doi: 10.1200/GO.20.00572. JCO Glob Oncol. 2021. PMID: 33739854 Free PMC article.
To improve outcomes of patients with MM in Western Kenya, the Academic Model Providing Access to Healthcare (AMPATH) MM Program was set up in 2012. In this article, the program's activities, challenges, and future plans are described distilling important lessons that can b …
To improve outcomes of patients with MM in Western Kenya, the Academic Model Providing Access to Healthcare (AMPATH) MM Program was set up i …
84 results